Mesker, Wilma E.

The Carcinoma–Stromal Ratio of Colon Carcinoma Is an Independent Factor for Survival Compared to Lymph Node Status and Tumor Stage

Mesker, W. E., Junggeburt, J. M. C., Szuhai, K., de Heer, P., Morreau, H., Tanke, H. J., & Tollenaar, R. A. E. M. (2007) · Analytical Cellular Pathology

Colorectal Cancer Surgical TreatmentsColorectal Cancer Treatments and Studies

Cited by 354

Scoring the tumor-stroma ratio in colon cancer: procedure and recommendations

van Pelt, G. W., Kjær-Frifeldt, S., van Krieken, J. H. J. M., Al Dieri, R., Morreau, H., Tollenaar, R. A. E. M., Sørensen, F. B., & Mesker, W. E. (2018) · Virchows Archiv

Colorectal Cancer Surgical TreatmentsColorectal Cancer Treatments and Studies

Cited by 192

The tumour–stroma ratio in colon cancer: the biological role and its prognostic impact

van Pelt, G. W., Sandberg, T. P., Morreau, H., Gelderblom, H., van Krieken, J. H. J. M., Tollenaar, R. A. E. M., & Mesker, W. E. (2018) · Histopathology

Cancer Cells and MetastasisColorectal Cancer Treatments and Studies

Cited by 155

Increased expression of cancer-associated fibroblast markers at the invasive front and its association with tumor-stroma ratio in colorectal cancer

Sandberg, T. P., Stuart, M. P. M. E., Oosting, J., Tollenaar, R. A. E. M., Sier, C. F. M., & Mesker, W. E. (2019) · BMC Cancer

Cancer Cells and MetastasisPancreatic and Hepatic Oncology Research

Cited by 135

Disorganised stroma determined on pre‐treatment breast cancer biopsies is associated with poor response to neoadjuvant chemotherapy: Results from the NEOZOTAC trial

Dekker, T. J. A., Charehbili, A., Smit, V. T. H. B. M., ten Dijke, P., Meershoek-Klein Kranenbarg, E., van de Velde, C. J. H., Nortier, J. W. R., Tollenaar, R. A. E. M., Mesker, W. E., & Kroep, J. R. (2015) · Molecular Oncology

Breast Cancer Treatment StudiesBreast Lesions and Carcinomas

Cited by 36

Predictive potential of tumour-stroma ratio on benefit from adjuvant bevacizumab in high-risk stage II and stage III colon cancer

Zunder, S. M., van Pelt, G. W., Gelderblom, H. J., Mancao, C., Putter, H., Tollenaar, R. A., & Mesker, W. E. (2018) · British Journal of Cancer

Colorectal Cancer Treatments and StudiesColorectal Cancer Surgical Treatments

Cited by 36

Self-supervised learning reveals clinically relevant histomorphological patterns for therapeutic strategies in colon cancer

Liu, B., Polack, M., Coudray, N., Claudio Quiros, A., Sakellaropoulos, T., Le, H., Karimkhan, A., Crobach, A. S. L. P., van Krieken, J. H. J. M., Yuan, K., et al. (2025) · Nature Communications

AI in cancer detectionRadiomics and Machine Learning in Medical Imaging

Cited by 25

A high tumour-stroma ratio (TSR) in colon tumours and its metastatic lymph nodes predicts poor cancer-free survival and chemo resistance

Strous, M. T. A., Faes, T. K. E., Gubbels, A. L. H. M., van der Linden, R. L. A., Mesker, W. E., Bosscha, K., Bronkhorst, C. M., Janssen-Heijnen, M. L. G., Vogelaar, F. J., & de Bruïne, A. P. (2022) · Clinical and Translational Oncology

Colorectal Cancer Surgical TreatmentsColorectal Cancer Treatments and Studies

Cited by 20

Stromal organization as predictive biomarker for the treatment of colon cancer with adjuvant bevacizumab; a post-hoc analysis of the AVANT trial

Zunder, S., van der Wilk, P., Gelderblom, H., Dekker, T., Mancao, C., Kiialainen, A., Putter, H., Tollenaar, R., & Mesker, W. (2019) · Cellular Oncology

Colorectal Cancer Treatments and StudiesColorectal Cancer Surgical Treatments

Cited by 9